Analysis of hematologic adverse events (HeAEs) in trifluridine/tipiracil (FTD/TPI)-treated patients (pts) with or without renal/hepatic impairment (RI/HI): Pooled safety analyses from TAGS and RECOURSE

George, B; Van Cutsem, E; Hochster, HS; Mayer, RJ; Ohtsu, A; Falcone, A; Yoshino, T; Doi, T; Ilson, DH; Arkenau, HT; Benhadji, KA; Makris, L; Tabernero, J; Shitara, K

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (4):